Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 92 of 100
Finance
Why drug companies are betting big on ‘pharmerging’ countries
By
Laura Lorenzetti
August 14, 2015
Health
CVS/Caremark will no longer cover these drugs, including Viagra
By
Chris Matthews
August 7, 2015
Features
Ackman’s back and Allergan — 5 things to know today
By
Tom Huddleston Jr.
and
Geoffrey Smith
August 6, 2015
Health
Shire offers to buy rival drugmaker Baxalta for $30 billion
By
Reuters
August 4, 2015
Finance
From Actavis to Allergan: One pharma company’s wild dealmaking journey
By
Stacy Jones
,
Kacy Burdette
and
Jen Wieczner
July 30, 2015
Tech
IBM Watson Health now counts CVS Health as a partner
By
Jonathan Vanian
July 30, 2015
Tech
Medical marijuana firm Potbotics to launch ‘virtual budtenders’
By
Dan Reilly
July 28, 2015
Finance
The real reasons for the pharma merger boom
By
Jen Wieczner
July 28, 2015
Features
The Fed, GM and a Twitter update–5 things to know today
By
Laura Lorenzetti
and
Geoffrey Smith
July 28, 2015
International
Israeli drug firm Teva buys Allergan’s generics business for $40 billion
By
Geoffrey Smith
July 27, 2015
Finance
Teva in talks to buy Allergan’s generic drug business
By
Reuters
July 26, 2015
International
World’s first malaria vaccine, from GlaxoSmithKline, wins approval from EU
By
Laura Lorenzetti
July 24, 2015
Tech
Just like with regular sports, eSports athletes will be tested for drugs
By
Chris Morris
July 24, 2015
Features
ISIS and drug sales — 5 things to know today
By
Tom Huddleston Jr.
and
Geoffrey Smith
July 24, 2015
Leadership
Doctors say cancer drug costs are out of control
By
Claire Groden
July 23, 2015
Most Popular
Middle East
Iran's attacks have collapsed, and the trend is 'overwhelmingly positive,' analysts say. But the military side is...
By
Jason Ma
Investing
Peter Thiel is actively convincing billionaires to abandon The Giving Pledge — and it may be working
By
Jake Angelo
Workplace Culture
Gen Z is dating less. The result is one of the most unprepared workforces
By
Jake Angelo